Endocrinology Medical News about Reversible Pancytopenia

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pioglitazone Induced Reversible Pancytopenia
Experimental and Clinical Endocrinology & Diabetes, 11/02/09

Karakurt F et al. – Pioglitazone is used to improve insulin sensitivity in type 2 diabetes. The authors report a patient who developed pancytopenia on the 7th day of oral pioglitazone treatment for the control of diabetes mellitus and fully recovered 6 days after the cessation of this drug. This is the first reported case of pancytopenia induced by pioglitazone therapy.

<< Previous
Carotid Atherosclerosis and a Reduced Likelihood for Lowered...

Next >>
A Polymorphism within the Fructosamine-3-kinase Gene is...

Successful treatment of refractory donor lymphocyte infusion-induced immune-mediated pancytopenia with rituximab
Pediatric Blood & Cancer, 11/10/09 Relevance Score: 44%

Is the reverse cycle during chewing abnormal in children with primary dentition
Journal of Oral Rehabilitation, 10/28/09 Relevance Score: 44%

5-Azacytidine Can Induce Lethal Mutagenesis in Human Immunodeficiency Virus Type 1
Journal of Virology, 10/28/09 Relevance Score: 43%

Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade
Cochrane Reviews, 10/19/09 Relevance Score: 43%

Reversal of Neuromuscular Blockade: Current Concepts & Future Developments
Journal of Anaesthesiology Clinical Pharmacology, 10/12/09 Relevance Score: 43%